Skip to main content
Premium Trial:

Request an Annual Quote

MoGene to Use Fluidigm Access Array for Targeted Resequencing Customers

Premium

Genomics service provider MoGene will use Fluidigm's Access Array sample preparation platform for its targeted resequencing customers, the companies said today.

MoGene, based in St. Louis, purchased an Access Array system to provide high-throughput target enrichment for "all major sequencing equipment," Shaukat Rangwala, vice president at MoGene, said in a statement.

According to the companies, Access Array is the only system that prepares amplicons for resequencing without the need for additional library preparation while providing low running costs and the ability to operate with any next-generation sequencer on the market.

Since 2004, MoGene has been involved with numerous sequencing projects such as transcriptomes, metagenomics, and sequencing the oil palm genome as a member of a consortium including Washington University and Orion Genomics.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.